| Literature DB >> 29093821 |
Hweemin Chung1, Kanwoo Youn1, Kyuyeon Kim1, Kyunggeun Park2.
Abstract
BACKGROUND: In Korea, Carbon disulfide (CS2) toxicity was an important social problem from the late 1980s to the early 1990s but there have been few large-scale studies examining the prevalence of diseases after CS2 exposure discontinuance. So we investigated past working exposure to CS2 characteristics from surviving ex-workers of a rayon manufacturing plant including cumulative CS2 exposure index. Furthermore, we studied the prevalence of their chronic diseases recently after many years.Entities:
Keywords: Carbon disulfide poisoning; Cumulative exposure estimate; Ex-workers; Rayon-manufacturing plant
Year: 2017 PMID: 29093821 PMCID: PMC5659026 DOI: 10.1186/s40557-017-0208-6
Source DB: PubMed Journal: Ann Occup Environ Med ISSN: 2052-4374
Standards of occupational accidents about CS2 poisoning or its secondary diseasesa
| 20. CS2 poisoning or its secondary diseases |
|---|
| Ga. A worker who has worked for more than two years on work exposed to CS2 vapor of around 10 ppm shall be considered as a work-related disease if any of the following symptoms or symptoms appear. |
| (1) When there is one of retinal microvessels, multiple cerebral infarction, capillary glomerulosclerosis on renal biopsy. |
| (2) Retinal lesions other than microvascular lesions, multiple peripheral nerve lesions, optic neuritis, coronary heart disease, central nervous system disorders or psychiatric disorders. |
| (3) There is one of (2) and there is at least one of kidney disorder, liver disorder, hematopoietic system disorder, reproductive system disorder, sensory nerve impairment disorder, and hypertension. |
| Na. A worker who is exposed to more than 20 ppm of CS2 vapor for more than two weeks shall be considered as a work-related disease if they present with sudden manifestations of mental disorders such as confusion, delirium, schizophrenia and bipolar disorder. |
| Da. When exposed to a large or high concentration of CS2 vapor, symptoms of acute intoxication such as consciousness disorder are regarded as occupational diseases. |
aIndustrial Accident Compensation Insurance Act, Article 39, Ministry of Labor, 1997
ICD-10 code of target disease
| Disease | Classification of 298 Diseasesa | ICD-10 codeb | |
|---|---|---|---|
| Hypertension | |||
| Essential(primary) hypertention | I10 | Essential (primary) hypertension | |
| I11 | Hypertensive heart disease | ||
| I12 | Hypertensive renal disease | ||
| I13 | Hypertensive heart and renal disease | ||
| I15 | Secondary hypertension | ||
| Coronary artery disease | |||
| Acute myocardial infarction | I20 | Angina pectoris | |
| I21 | Acute myocardial infarction | ||
| I22 | Subsequent myocardial infarction | ||
| I23 | Certain current complications following acute myocardial infarction | ||
| I24 | Other acute ischaemic heart diseases | ||
| I25 | Chronic ischemic heart disease | ||
| Cerebrovascular disease | |||
| Transient cerebral ischaemic attacks and related syndromes | G45 | Transient cerebral ischaemic attacks and related syndromes | |
| G50 | Disorders of trigeminal nerve | ||
| G51 | Facial nerve disorders | ||
| G52 | Disorders of other cranial nerves | ||
| G53 | Cranial nerve disorders in diseases classified elsewhere | ||
| G80 | Cerebral palsy | ||
| G81 | Hemiplegia | ||
| G82 | Paraplegia and tetraplegia | ||
| G83 | Other paralytic syndromes | ||
| Diabetes mellitus | |||
| Diabetes mellitus | E10 | Type 1 diabetes mellitus | |
| E11 | Type 2 diabetes mellitus | ||
| E12 | Malnutrition-related diabetes mellitus | ||
| E13 | Other specified diabetes mellitus | ||
| E14 | Unspecified diabetes mellitus | ||
| Arrhythmia | |||
| Conduction disorders and cardiac arrhythmias | I44 | Atrioventricular and left bundle-branch block | |
| I45 | Other conduction disorders | ||
| I46 | Cardiac arrest | ||
| I47 | Paroxysmal tachycardia | ||
| I48 | Atrial fibrillation and flutter | ||
| I49 | Other cardiac arrhythmias | ||
| Psychoneurotic disorder | |||
| Schizophrenia schizotypal and delusional disorders | F20 | Schizophrenia | |
| F21 | Schizotypal disorder | ||
| F22 | Persistent delusional disorders | ||
| F23 | Acute and transient psychotic disorders | ||
| F24 | Induced delusional disorder | ||
| F25 | Schizoaffective disorders | ||
| F28 | Other nonorganic psychotic disorders | ||
| F29 | Unspecified nonorganic psychosis | ||
| F40 | Phobic anxiety disorders | ||
| F41 | Other anxiety disorders | ||
| F42 | Obsessive-compulsive disorder | ||
| F43 | Reaction to severe stress, and adjustment disorders | ||
| F44 | Dissociative [conversion] disorders | ||
| F45 | Somatoform disorders | ||
| F48 | Other neurotic disorders | ||
| Disorders of the nervous system and sensory organs | |||
| Nerve, nerve root and plexus disorders | G12 | Spinal muscular atrophy and related syndromes | |
| G13 | Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere | ||
| G21 | Secondary parkinsonism | ||
| G22 | Parkinsonism in diseases classified elsewhere | ||
| G24 | Dystonia | ||
| G25 | Other extrapyramidal and movement disorders | ||
| G26 | Extrapyramidal and movement disorders in diseases classified elsewhere | ||
| G37 | Other demyelinating diseases of central nervous system | ||
| G56 | Mononeuropathies of the upper limb | ||
| G57 | Mononeuropathies of the lower limb | ||
| G58 | Other mononeuropathies | ||
| G59 | Mononeuropathy in diseases classified elsewhere | ||
| G62 | Other polyneuropathies | ||
| G64 | Other disorders of the peripheral nervous system | ||
| G70 | Myasthenia gravis and other myoneural disorders | ||
| G72 | Other myopathies | ||
| G73 | Disorders of the myoneural junction and muscle in diseases classified elsewhere | ||
| G90 | Disorders of the autonomic nervous system | ||
| G92 | Toxic encephalopathy | ||
| G93 | Other disorders of the brain | ||
| G94 | Other disorders of the brain in diseases classified elsewhere | ||
| G95 | Other diseases of the spinal cord | ||
| G96 | Other disorders of the central nervous system | ||
| G98 | Other disorders of the nervous system not elsewhere classified | ||
| G99 | Other disorders of the nervous system in diseases classified elsewhere | ||
a2015 National Health Insurance Statistical Yearbook
bInternational Classification of Disease-10
Establishing criteria for CS2 exposure concentration by department
| Department | CS2 -exposed Concentration (ppm) | Job Contents |
|---|---|---|
| High exposure concentration department | ||
| Spinning | ||
| Doping | 6.53 | Threading up a spinning machinery and taking out the cake, As CS2 is released during rayon regeneration, exposure concentration is highest with direct exposure. |
| Circuit | 6.58 | In the spinning room having a tangled or broken thread, As CS2 is released during rayon regeneration, exposure concentration is highest with direct exposure. |
| Motor Repair | 3.79 | Repairing motors of a spinning machinery |
| Moderate exposure concentration department | ||
| Electrical Equipment Repair | 4.33 | High amount of spinning room work while repairing electrical equipment due to mechanical corrosion problems. |
| Maitenance of Ejector | 3.03 | It is intermittent for reasons such as machine maintenance, but working within the spinning department |
| Collection of Sulfuric acid | 3.79 | CS2 mixed in the recovered solution. |
| Manufacturing of CS2 | 2.77 | Exposure to high concentrations of CS2 for a short time while manufacturing, but protective gear is used. |
| Post-Process | ||
| Packing | 3.6 | Restricted to the spinning room |
| Carrying | 1.96 | Working in a spinning room for a long time to transport rayon. |
| Refining | 2 | Exposure to remaining CS2 while processing semi-finished cake |
| Maintenance | 2.16 | Estimated at 50% of that in the electrical equipment repair department |
| Manufacturing of Viscose | 1.35 | |
| Low exposure concentration department | ||
| Water Treatment | 0.45 | Sewage inspection and cleaning in the spinning room |
| Manufacturing of Chemicals | 0.23 | Estimated at 50% of that in the water treatment department, production of caustic soda and liquid chlorine, lower possibility of direct exposure. |
| General Affairs | 0.12 | Estimated at 50% of that in the manufacturing department |
Setting weight by operating period
| Operating Period (year) | Weight by period | Evidence |
|---|---|---|
| 1966 (Initial operation)-1974 | 3.5 | The average concentration of CS2 in the spinning division in the 1960s (20 ppm) was about 3.5 times the average concentration of the total spinning division measured in 1991 (5.6 ppm). |
| 1975–1989 | 2.75 | The average concentration in the spinning division measured in the 70s and 80s (10–15 ppm) was about 2.25 times the average concentration in the total spinning division measured in 1991 (5.6 ppm). |
| 1990–1993 (Upon closure) | 0.5 | The compliance towards wearing personal protective gear was relatively good. |
Calculation of the cumulative exposure index and time-weighted average concentration of CS2
| • cumulative exposure index (CEI) = Σ (working years x reference concentration x weight) | |
| • time weighted average CS2 concentration = Σ (the hours in the workday x reference concentration x weight) / the hours in the workday of exposure to CS2 |
Demographic and employment characteristics of the study subjects
| Number of the subjects | Mean | SD | |||
|---|---|---|---|---|---|
| N | % | ||||
| Demographic characteristics | |||||
| Total | 633 | 100.0 | |||
| Sex | Male | 546 | 86.3 | ||
| Female | 87 | 13.7 | |||
| Age distribution (year) | 50–59 | 57 | 52.6 | ||
| 60–69 | 196 | 69.4 | |||
| ≥ 70 | 380 | 71.6 | |||
| Smoking | No | 212 | 33.5 | ||
| Yes | 385 | 60.8 | |||
| No answer | 36 | 5.7 | |||
| Alcohol consumption (days/week) | <1 | 336 | 53.1 | ||
| ≥1 | 260 | 41.1 | |||
| No answer | 37 | 5.9 | |||
| Employment characteristics | |||||
| Age at first employment (years) | 27.9 | 5.3 | |||
| Age at date last observed among survivors (years) | 70.7 | 7.5 | |||
| Year in the first employment (year) | 1974.2 | 6.2 | |||
| <1975 | 339 | 53.6 | |||
| 1975–1993 | 294 | 46.4 | |||
| Duration of employment (years) | 12.8 | 5.6 | |||
| <10 | 204 | 29.7 | |||
| 10–<20 | 379 | 59.9 | |||
| ≥20 | 66 | 10.4 | |||
| Cumulative CS2 exposure index (ppm·yr) | 128.2 | 82.2 | |||
| 0–<67a | 169 | 26.7 | |||
| 67–<134 | 206 | 32.5 | |||
| ≥134b | 258 | 40.8 | |||
| Time-weighted average CS2 concentration (ppm) | 10.1 | 4.9 | |||
| 0- < 5c | 112 | 17.7 | |||
| 5–<10d | 199 | 31.4 | |||
| ≥10 | 322 | 50.9 | |||
| Department distribution by CS2 exposure concentration | |||||
| Low (<5 ppm)e | 340 | 53.7 | |||
| High (≥5 ppm) | 293 | 46.3 | |||
alower one third defined by distribution of metric among all the study subject
bupper one third defined by distribution of metric among all the study subject
cEU - Commission Directive 2006/15/EC of 7 February 2006 establishing a second list of indicative occupational exposure limit values
dIndustrial Safety and Health Act enforcement regulations separate Table 3 of 11 Amendment of allowable standard of exposure concentration by harmful factor, IRE - 2010 Code of Practice for the Safety, Health and Welfare at Work (Chemical Agents) Regulations 2001. Published by the Health and Safety Authority
eEU - Commission Directive 2006/15/EC of 7 February 2006 establishing a second list of indicative occupational exposure limit values
CS2 exposure concentrations by department
| Workers Exposed to CS2 (%) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Department ( | |||||||||||||
| Spinning | Electrical Equipment Repair | Motor Repair | Collection of Sulfuric acid | Maintenance of ejector | Manufacturing of CS2 | Post-Process | Refining | Maintenance | Manufacturing of Viscose | Water Treatment | General Affairs | ||
| CS2 exposure concentrationa (ppm) | |||||||||||||
| 0- < 5b | N | 10 | 1 | 0 | 0 | 1 | 0 | 37 | 2 | 9 | 52 | 0 | 0 |
| % | 3.6 | 7.7 | 0.0 | 0.0 | 2.5 | 0.0 | 25.5 | 25.0 | 56.3 | 96.3 | 0.0 | 0.0 | |
| 5- < 10c | N | 9 | 2 | 10 | 12 | 31 | 11 | 107 | 6 | 7 | 1 | 2 | 1 |
| % | 3.2 | 15.4 | 38.5 | 34.3 | 77.5 | 91.7 | 73.8 | 75.0 | 43.7 | 1.9 | 100.0 | 50.0 | |
| ≥10 | N | 261 | 10 | 16 | 23 | 8 | 1 | 1 | 0 | 0 | 1 | 0 | 1 |
| % | 93.2 | 76.9 | 61.5 | 65.7 | 20.0 | 8.3 | 0.7 | 0.0 | 0.0 | 1.8 | 0.0 | 50.0 | |
| total (N) | 280 | 13 | 26 | 35 | 40 | 12 | 145 | 8 | 16 | 54 | 2 | 2 | |
aTime-weighted average CS2 concentration
bEU - Commission Directive 2006/15/EC of 7 February 2006 establishing a second list of indicative occupational exposure limit values
cIndustrial Safety and Health Act enforcement regulations separate Table 3 of 11 Amendment of allowable standard of exposure concentration by harmful factor, IRE - 2010 Code of Practice for the Safety, Health and Welfare at Work (Chemical Agents) Regulations 2001. Published by the Health and Safety Authority
Disease prevalence for the study subjects
| Observed Events | Study population | Disease Prevalence | ||
|---|---|---|---|---|
| N | N | % | ||
| Disease | ||||
| Hypertension | 438 | 633 | 69.2 | |
| Coronary artery disease | 88 | 633 | 13.9 | |
| Cerebrovascular disease | 157 | 633 | 24.8 | |
| Diabetes mellitus | 155 | 633 | 24.5 | |
| Arrhythmia | 8 | 633 | 1.3 | |
| Psychoneurotic disorder | 416 | 633 | 65.7 | |
| Disorders of the nervous system and sensory organs | 458 | 633 | 72.4 | |